A little-known ASX stock that represents a supplier for the ubiquitous Chemist Warehouse chain is set to zoom ahead this year.
That’s the opinion of Prime Value portfolio manager Shih Thin Wong, who said that in turbulent times such as now, businesses with resilient demand would win.
“I want to be comfortable owning companies which I think will give me earnings growth profile regardless of the macro environment,” he told Switzer TV Investing.
“And can control a number of elements that will drive growth internally… And I want to be owning companies that are less reliant on what’s happening in the global financial markets.”
We’ll continue to buy regardless of economy
One ASX share that fits all those criteria is New Zealand’s EBOS Group Ltd (ASX: EBO), according to Wong.
“It’s not a company which is really followed by Australian fund managers that closely. But it’s a hidden gem in the mid-cap space.”
Wong notes that one of EBOS’ clients is a huge retailer that all Australians will have shopped at one time or another.
“It really is a key supplier to Chemist Warehouse, which we know is growing very strongly. So there’s growth in that pipeline.”
In times of rising interest rates and wars, pharmacy and medical supplies industries are known to be robust.
“We’re comfortable that it’s got 8% to 12% earnings growth in the next 2 to 3 years,” said Wong.
“We will continue to buy pharmacy products whether the economy is good or bad.”
There is also an acquisition that EBOS will settle in the coming 24 months, which will bring it earnings growth, according to Wong.
“The management of this company is really strong.”
EBOS, which is dual-listed on the NZX and ASX, has a market capitalisation of $6.9 billion.
Its ASX shares have lost about 7% for the year so far, closing Friday at $36.05.
According to CMC Markets, 6 out of 10 analysts currently rate the stock as a “buy”. Five of them consider it as a “strong buy”.
The post Why this $7 billion ASX-listed company is a ‘hidden gem’: expert appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- Analyst tips 20% upside and 6.5% dividend yield for this ASX share
- 5 things to watch on the ASX 200 on Monday
- Analysts name 2 ASX 200 dividend giants to buy in March
- 2 ASX shares rated as strong buys by brokers
- 3 buy-rated ASX growth shares analysts are recommending
Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/lVUOzB7
Leave a Reply